Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

EF Hutton Reiterates Buy on Upexi, Maintains $7 Price Target

EF Hutton analyst Michael Albanese reiterates Upexi (NASDAQ:UPXI) with a Buy and maintains $7 price target.
byBenzinga Newsdesk
February 15, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

EF Hutton analyst Michael Albanese reiterates Upexi (NASDAQ:UPXI) with a Buy and maintains $7 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Renovaro Biosciences Responds To Hindenburg’s Recent Opinion Piece, Says “The Board And Management Remain Confident In The Future Of The Company And Believe People Will See These Baseless Attacks For What They Are.”

By Benzinga Newsdesk
February 14, 11:04 AM
The following is a statement by Renovaro (NASDAQ:RENB) in response to Hindenburg's recent opinion piece:We felt compelled to comment on the shorter Hindenburg's opinion piece.The one thing Hindenburg got right is that

RENB